遠東生物科技股份有限公司 Approved
最後更新時間 2025/06/16 , 01:19 PM
最後更新時間 2025/06/16 , 01:19 PM
負責人
Que,Zhuang-Qun
統一編號
23625631
成立日期
1990/02/28
資本額
NT$600,000,000
實收資本額
NT$302,380,000
股票代號
6886
電話
02-26558198
地址
13F, No. 3, Park St., Nangang Dist., Taipei City, 115, Taiwan
董監事
姓名 職稱 持有股份 代表法人
Que,Zhuang-Qun Chairman 14.22%
Mai,Shu-E Director 38.12% XIN HONG ENTERPRISE CO., LTD.
Zheng,Shang-Hao Director 0.00%
Bai,Wan-Ting Independent Director 0.00%
Yan,Zhi-Ming Independent Director 0.00%
Guo,Deng-Fu Independent Director 0.00%
Xiao,Yu-Juan Independent Director 0.00%
營業項目
  • Wholesale of Other Food(454999)
  • Retail Sale of Other Food, Beverages and Tobacco in Specialized Stores(472999)
  • Other Professional, Scientific and Technical Activities Not Elsewhere Classified(760999)
  • Wholesale of Pharmaceutical and Medical Goods(457112)
  • 公司歷程
  • Change Capital to 305,184,000
    2020/03/03
  • 員工人數
    下載完整報告查看完整數據
    財務報表
    項目 2024 2023 2022
    Operating income 168,920 306,188 379,734
    Operating cost 86,865 163,945 165,039
    Profit (loss) of initial recognition of biological asset and agricultural products - - -
    Profit (loss) on changes in fair value less costs to sell of biological asset for current period - - -
    Operating gross profit (loss) 82,055 142,243 214,695
    Unrealized profit (loss) on sales of goods - - -
    Realized profit (loss) on sales of goods - - -
    Operating gross profit (loss), net 82,055 142,243 214,695
    Operating expenses 55,854 115,568 105,278
    Other gain (loss), net - - -
    Operating profit (loss) 26,201 26,675 109,417
    Non-operating income and expenses 3,001 7,691 3,100
    Net profit (loss) before tax 29,202 34,366 112,517
    Income tax expense (benefits) 7,941 6,973 21,854
    Net profit (loss) of ongoing business for the current period 21,261 27,393 90,663
    Profit (loss) of closed units - - -
    Profit (loss) of non-jointly controlled equity before merger - - -
    Net profit (loss) for the current period 21,261 27,393 90,663
    Other comprehensive profit (loss), net 0 524 151
    Comprehensive net profit and loss of non-jointly controlled equity before merger - - -
    Total comprehensive profit and loss for the current period 21,261 27,917 90,814
    Net profit (loss) attributable to owners of parent company 21,261 27,393 90,663
    Net profit (loss) form equity attributable to former owner of business combination under common control - - -
    Net profit (loss) attributable to non-controlling interests 0 0 0
    Comprehensive profit (loss) attributable to owners of parent company 21,261 27,917 90,814
    Comprehensive profit (loss) form equity attributable to former owner of business combination under common control - - -
    Comprehensive profit (loss) attributable to non-controlling interests 0 0 0
    Basic earnings per share (yuan) 0 1 3
    項目 2024 2023 2022
    Net cash inflow (outflow) from operating activities 32,855 -2,085 106,796
    Net cash inflows (outflows) from investing activities -64,855 -14,493 -30,374
    Net cash inflow (outflow) from financing activities -3,881 21,229 -32,816
    Effect of Exchange Rate Changes on Cash and Cash Equivalents 0 655 18
    Increase (decrease) in cash and cash equivalents in the current period -35,881 5,306 43,624
    Beginning balance of cash and cash equivalents 301,267 295,961 252,337
    Ending balance of cash and cash equivalents 265,386 301,267 295,961
    項目 2024 2023 2022
    Current asset 397,704 433,057 408,885
    Non-current asset 231,021 136,430 136,863
    Total asset 628,725 569,487 545,748
    Current liability 92,339 59,189 87,556
    Non-current liability 54,087 21,673 26,682
    Total liability 146,426 80,862 114,238
    share capital 291,900 278,000 250,000
    Equity - secruity token - - -
    capital reserve 112,852 112,639 36,381
    retained earning 77,472 97,911 145,578
    Other equity 75 75 -449
    Treasury stock - - -
    Total equity attributable to owners of parent company 482,299 488,625 431,510
    Equity attributable to former owner of business combination under common control - - -
    Equity attributable to non-controlling interest before business merger under common control - - -
    Non-controlling interests - - 0
    Total Equity 482,299 488,625 431,510
    Share capital awaiting retirement (unit: share) 0 0 0
    Issued shares of advance equity (unit: shares) 0 0 0
    Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) 0 0 0
    Net asset value per share 17 17 17
    動產抵押
    下載完整報告查看完整數據
    案件類別 債務人名稱 債務人統編 契約啟始日期 契約終止日期 抵押權人名稱 抵押權人統編 擔保債權金額
    選舉收入(政治獻金)
    收入名稱 收入金額
    總收入金額
    選舉支出(政治獻金)
    支出名稱 支出金額
    總支出金額
    標案拒往
    機關名稱 生效日期 截止日期
    進出口資料
    下載完整報告查看完整數據
    年份 月份 總進口實績(美金) 總出口實績(美金)
    商標
  • FEBICO IN
  • 遠東晶彩
  • 股立固力
  • ZAOYO OPTIMIZE
  • Apox 寶護尼
  • 藻優
  • 藻安
  • 噴必清
  • Apogen
  • 登少年
  • 專利
    政府標案
    標案名稱 機關名稱 決標日期 決標金額 是否得標
    裁判書查詢
  • Compensation for damage
    2011
  • Others
    2006, 2023
  • Payment order
    2012, 2014, 2023
  • Trademark Law
    2006
  • Motion of objection
    2023
  • Infringement damage compensation
    2007
  • 勞權違規
    日期 違反法規法條 罰鍰金額
    污染源裁處
    污染類別 裁處時間 裁處機關 裁處金額 違反事實 違反法令 裁處書字號 裁處理由及法令 公司地址
    本頁內所載之資料,所載資料之完整性、即時性和正確性仍應以資料來源單位為準。
    公司一有新動態,我們馬上通知你,追蹤公司讓你不錯過任何更新。